Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Clinical trial NCT05523895 · COMPLETED
Trial details
- NCT number
- NCT05523895
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2024-09-27
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.